Getinge AB

Common Name
Getinge
Country
Sweden
Sector
Healthcare
Industry
Medical Devices
Employees
11,874
Ticker
GETI B
Exchange
NASDAQ STOCKHOLM AB
Description
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therap...

Financial Statements of Getinge

Below are the financial statements of Getinge, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in billions of SEK20242023
Net sales
34.76a
31.83a
Cost of goods sold
-18.61a
-17.33a
Gross profit
16.15a
14.5a
Selling expenses
-5.98a
-5.37a
Administrative expenses
-4.65a
-4.32a
Research and development costs
-1.43a
-1.19a
Acquisition expenses
-0.05a
-0.17a
Restructuring costs
-0.85a
-0.08a
Other operating income
0.67a
1.03a
Other operating expenses
-1.01a
-0.67a
Operating profit (EBIT)
2.85a
3.74a
Interest income and other similar income
0.11a
0.17a
Interest expenses and other similar expenses
-0.68a
-0.56a
Profit after financial items
2.28a
3.34a
Taxes
-0.63a
-0.92a
Net profit for the year
1.65a
2.43a
Net profit for the year attributable to
Parent company's shareholders
1.64a
2.41a
Non-controlling interests
0.02a
0.02a
Download Data

Verified Sources Behind Getinge’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Getinge’s data sources below and access millions more through our Disclosure Search.

a. Getinge's Annual Report 2024
a. Getinge's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?